BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8595162)

  • 21. Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.
    Papa V; Gliozzo B; Clark GM; McGuire WL; Moore D; Fujita-Yamaguchi Y; Vigneri R; Goldfine ID; Pezzino V
    Cancer Res; 1993 Aug; 53(16):3736-40. PubMed ID: 8339284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
    Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
    J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-I (IGF-I) system during follicle development in the bovine ovary: relationship among IGF-I, type 1 IGF receptor (IGFR-1) and pregnancy-associated plasma protein-A (PAPP-A).
    Sudo N; Shimizu T; Kawashima C; Kaneko E; Tetsuka M; Miyamoto A
    Mol Cell Endocrinol; 2007 Jan; 264(1-2):197-203. PubMed ID: 17116363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients.
    Railo MJ; von Smitten K; Pekonen F
    Eur J Cancer; 1994; 30A(3):307-11. PubMed ID: 8204350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cells.
    Murphy LJ; Sutherland RL; Lazarus L
    Biochem Biophys Res Commun; 1985 Sep; 131(2):767-73. PubMed ID: 2996526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oestradiol enhances plasma growth hormone and insulin-like growth factor-I concentrations and increased the expression of their receptors mRNAs in the liver of ovariectomized cows.
    Colak M; Shimizu T; Matsunaga N; Murayama C; Nagashima S; Kataoka M; Kawashima C; Matsui M; van Dorland HA; Bruckmaier RM; Miyamoto A
    Reprod Domest Anim; 2011 Oct; 46(5):854-61. PubMed ID: 21323755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.
    Musgrove EA; Lee CS; Sutherland RL
    Mol Cell Biol; 1991 Oct; 11(10):5032-43. PubMed ID: 1922031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumor promoters in human mammary carcinoma cells.
    Roos W; Fabbro D; Küng W; Costa SD; Eppenberger U
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):991-5. PubMed ID: 3006036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype.
    Need EF; Selth LA; Trotta AP; Leach DA; Giorgio L; O'Loughlin MA; Smith E; Gill PG; Ingman WV; Graham JD; Buchanan G
    BMC Cancer; 2015 Oct; 15():791. PubMed ID: 26498662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
    Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor receptor is required for estradiol-stimulated bovine satellite cell proliferation.
    Reiter BC; Kamanga-Sollo E; Pampusch MS; White ME; Dayton WR
    Domest Anim Endocrinol; 2014 Jul; 48():48-55. PubMed ID: 24906928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential stimulation of human progesterone receptor B expression by estrogen in T-47D human breast cancer cells.
    Graham JD; Roman SD; McGowan E; Sutherland RL; Clarke CL
    J Biol Chem; 1995 Dec; 270(51):30693-700. PubMed ID: 8530508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
    Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
    Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand.
    Press MF; Xu SH; Wang JD; Greene GL
    Am J Pathol; 1989 Nov; 135(5):857-64. PubMed ID: 2683797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
    Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.